Safeguarding vaccine production and supply strategies for polio eradication endgame
Authors:
Open Access
- 1 June 2021
- journal article
- letter
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 11, 100159
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trialThe Lancet Regional Health - Western Pacific, 2021
- Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialThe Lancet Infectious Diseases, 2021
- Final frontiers of the polio eradication endgameCurrent Opinion in Infectious Diseases, 2020
- Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication EraEmerging Infectious Diseases, 2019
- Sabin Strain Inactivated Polio Vaccine for the Polio EndgameThe Journal of Infectious Diseases, 2019
- Next Generation Inactivated Poliovirus Vaccine: The Future Has ArrivedClinical Infectious Diseases, 2017